Kenichi Sakamoto

Kenichi Sakamoto

Auto-generated profile, based on publicly available information

Kenichi Sakamoto

Division of Endocrinology, Metabolism & Nutrition, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, USA

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2021 in Nature Reviews Endocrinology
Verified
Journal Article
Closed access
PDF file
TSThomas Scherer
Thomas Scherer
KSKenichi Sakamoto
Kenichi Sakamoto
CBChristoph Buettner
Christoph Buettner

1 September 1992 in Journal of General Virology
Verified
Journal Article
Open access
NMNoriko Mizukoshi
Noriko Mizukoshi
KSKenichi Sakamoto
Kenichi Sakamoto
AIAkira Iwata
Akira Iwata
TTTakeshi Tsuchiya
Takeshi Tsuchiya
SUSusumu Ueda
Susumu Ueda
AFAkio Fukusho
Akio Fukusho
The complete sequence of RNA segment 5 of the African horsesickness virus serotype 4 (AHSV-4) vaccine strain was determined from cDNA clones inserted into pBR322. The RNA is 1751 bp long (M r 1.12 × 106) and contains an open reading frame encoding a protein of 548 amino acids (M r 63 122) with a net charge of +0.5 at neutral pH. A comparison of the sequence of AHSV-4 segment 5 with that of segment 6 of bluetongue virus (BTV) serotypes 10 and 17 revealed 49.2% and 48.9% nucleotide similarity, respectively, and 31.4% amino acid similarity. However, AHSV-4 segment 5 has no significant similarity to BTV segment 5. In addition, Northern blot hybridization showed that full-length AHSV-4 segment 5 cDNA cross-hybridized with the corresponding genes of all serotypes of attenuated AHSV.


1 January 2012 in The Japanese Journal of Gastroenterological Surgery
Verified
Journal Article
Open access
PDF file
MKMasaki Kimura
Masaki Kimura
TYTakuya Yamada
Takuya Yamada
YKYoshihiko Kato
Yoshihiko Kato
TSTakafumi Sekino
Takafumi Sekino
KSKenichi Sakamoto
Kenichi Sakamoto
HTHirofumi Takemura
Hirofumi Takemura

23 November 2019 in Journal of Diabetes Investigation
Verified
Journal Article
Open access
PDF file
KSKenichi Sakamoto
Kenichi Sakamoto
KYKoutaro Yokote
Koutaro Yokote
The recent increase in the global incidence of Type 2 diabetes mellitus (DM) poses major threats to societies worldwide. Patients with DM are at heightened risk of vascular complication such as cardiovascular diseases (CVD), including stroke. Many studies revealed that glycemic control improves cardiovascular outcome in DM patient, however the relationship linking DM to CVD is more complex and multifaceted in nature.